These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29518412)

  • 1. Electrophysiological determination of phosphodiesterase-6 inhibitor inhibition constants in intact mouse retina.
    Turunen TT; Koskelainen A
    Toxicol Appl Pharmacol; 2018 Apr; 345():57-65. PubMed ID: 29518412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors.
    Zhang X; Feng Q; Cote RH
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3060-6. PubMed ID: 16123402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6.
    Leinonen H; Cheng C; Pitkänen M; Sander CL; Zhang J; Saeid S; Turunen T; Shmara A; Weiss L; Ta L; Ton T; Koskelainen A; Vargas JD; Kimonis V; Palczewski K
    J Pharmacol Exp Ther; 2021 Jul; 378(1):31-41. PubMed ID: 33931547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase.
    Behn D; Potter MJ
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):523-7. PubMed ID: 11157892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency and mechanism of action of E4021, a type 5 phosphodiesterase isozyme-selective inhibitor, on the photoreceptor phosphodiesterase depend on the state of activation of the enzyme.
    D'Amours MR; Granovsky AE; Artemyev NO; Cote RH
    Mol Pharmacol; 1999 Mar; 55(3):508-14. PubMed ID: 10051534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the ILE86TER mutation in the γ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling.
    Tsang SH; Woodruff ML; Lin CS; Jacobson BD; Naumann MC; Hsu CW; Davis RJ; Cilluffo MC; Chen J; Fain GL
    Cell Signal; 2012 Jan; 24(1):181-8. PubMed ID: 21920434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5.
    Cote RH
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S28-33. PubMed ID: 15224133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional modulation of phosphodiesterase-6 by calcium in mouse rod photoreceptors.
    Turunen T; Koskelainen A
    Sci Rep; 2021 Apr; 11(1):8938. PubMed ID: 33903621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei.
    Rascón A; Soderling SH; Schaefer JB; Beavo JA
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4714-9. PubMed ID: 11930017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB; Thompson WJ; Pittler SJ
    Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
    Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
    Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct allosteric regulation between the GAF domain and catalytic domain of photoreceptor phosphodiesterase PDE6.
    Zhang XJ; Cahill KB; Elfenbein A; Arshavsky VY; Cote RH
    J Biol Chem; 2008 Oct; 283(44):29699-705. PubMed ID: 18779324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
    Day JP; Dow JA; Houslay MD; Davies SA
    Biochem J; 2005 May; 388(Pt 1):333-42. PubMed ID: 15673286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the catalytic sites and activation mechanism of photoreceptor phosphodiesterase using radiolabeled phosphodiesterase inhibitors.
    Liu YT; Matte SL; Corbin JD; Francis SH; Cote RH
    J Biol Chem; 2009 Nov; 284(46):31541-7. PubMed ID: 19758990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948.
    Gillespie PG; Beavo JA
    Mol Pharmacol; 1989 Nov; 36(5):773-81. PubMed ID: 2555675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibitor sensitivity between human recombinant and native photoreceptor cGMP-phosphodiesterases (PDE6s).
    Zhang J; Kuvelkar R; Wu P; Egan RW; Billah MM; Wang P
    Biochem Pharmacol; 2004 Sep; 68(5):867-73. PubMed ID: 15294449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants of phosphodiesterase 6 response on binding catalytic site inhibitors.
    Simon A; Barabás P; Kardos J
    Neurochem Int; 2006 Aug; 49(3):215-22. PubMed ID: 16519963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenylquinazolin-4(3H)-one, a class of potent PDE5 inhibitors with high selectivity versus PDE6.
    Duan H; Zheng J; Lai Q; Liu Z; Tian G; Wang Z; Li J; Shen J
    Bioorg Med Chem Lett; 2009 May; 19(10):2777-9. PubMed ID: 19375311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC; Anderson N; Peachell PT
    Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.